Mice Model Market, By Model Type (Genetically Engineered Mice (GEM) (Knockout Mice, Knock-in Mice, and Conditional Mutant Mice), Inbred Mice, Outbred Mice, Hybrid/Congenic Mice, and Spontaneous Mutant Mice), By Service (Breeding Services, Cryopreservation, Rederivation, and Resequencing Services, Genetic Testing and Characterization Services, Model In-vivo and In-vitro Testing Services, and Custom Model Development Services), By Technology (CRISPR/Cas9, Embryonic Stem Cell (ESC) Technology, Nuclear Transfer Technology, Microinjection Technology, and Others (e.g., TALENs, ZFNs)), By Application (Oncology Research, Immunology and Inflammation Studies, Diabetes Research, Cardiovascular Research, Neurological Disease Research, Rare Disease Research, Toxicology and Safety Assessment, and Others (e.g., Metabolic Disorders, Infectious Diseases)), By End User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutions, Contract Research Organizations (CROs), and Government and Nonprofit Organizations), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)